FMN
OCUL icon

Financial Management Network’s Ocular Therapeutix OCUL Stock Holding History

Financial Management Network’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$197K Hold
22,000
– – 0.03% 211
2026
Q1 		$205K Buy
+22,000
New +$210K 0.03% 191

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Financial Management Network's OCUL Position: Q2 2026 in Review

Financial Management Network held its Ocular Therapeutix (OCUL) position steady in Q2 2026 at 22,000 shares worth $197K. The position accounts for 0.03% of the portfolio, ranked #211.

Financial Management Network first reported a position in OCUL in Q1 2026 and has held it in 2 quarters since. The position peaked at $205K in Q1 2026. 261 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

  • Financial Management Network held 22,000 shares of Ocular Therapeutix worth $197K as of Q2 2026.
  • Financial Management Network left its Ocular Therapeutix share count unchanged in Q2 2026.
  • Ocular Therapeutix made up 0.03% of Financial Management Network's portfolio in Q2 2026, its #211 holding.
  • Financial Management Network first reported a position in Ocular Therapeutix in Q1 2026 and has held it in 2 quarters since.
  • Financial Management Network's Ocular Therapeutix position peaked at $205K in Q1 2026.
  • 261 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on Financial Management Network's 13F filing for Q2 2026, filed 6 Aug 2026.